Diabetes, Vol 38, Issue 4 504-509, Copyright © 1989 by American Diabetes Association

ARTICLES

Diabetes, intermittent claudication, and risk of cardiovascular events. The Framingham Study

FN Brand, RD Abbott and WB Kannel
Section of Preventive Medicine and Epidemiology, Boston University School of Medicine, Evans Research Foundation, Boston, Massachusetts.

The impact of diabetes on intermittent claudication was examined in 1813 men and 2504 women with 34-yr follow-up data in the Framingham study. For both sexes, diabetes was associated with a two- to threefold excess risk of intermittent claudication compared with its absence. A pronounced excess risk was also observed in subjects on oral hypoglycemic therapy and in women receiving insulin. Although diabetes was often associated with an atherogenic-risk profile, controlling for age and several concomitant risk factors failed to eliminate the association with intermittent claudication. Those who developed both intermittent claudication and diabetes were at an especially high risk of incident cardiovascular events. In women, the risk of coronary heart disease, stroke, and cardiac failure was increased 3-4 times when diabetes and intermittent claudication occurred together compared with when either condition existed alone. In diabetic men, the presence of intermittent claudication doubled the risk of stroke, and cardiac failure was approximately 3 times more likely in subjects with both conditions compared with either alone. We conclude that diabetes is an important risk factor for intermittent claudication, which in turn confers a serious prognosis for subsequent cardiovascular outcomes in the patient with diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				B. You, A. Ren, G. Yan, and J. Sun Activation of Sphingosine Kinase-1 Mediates Inhibition of Vascular Smooth Muscle Cell Apoptosis by Hyperglycemia Diabetes, May 1, 2007; 56(5): 1445 - 1453. [Abstract] [Full Text] [PDF]

				H. Bazari, M. R. Jaff, M. Mannstadt, and S. Yan Case 7-2007 -- A 59-Year-Old Woman with Diabetic Renal Disease and Nonhealing Skin Ulcers N. Engl. J. Med., March 8, 2007; 356(10): 1049 - 1057. [Full Text] [PDF]

				D. W. Bowden, M. Rudock, J. Ziegler, A. B. Lehtinen, J. Xu, L. E. Wagenknecht, D. Herrington, S. S. Rich, B. I. Freedman, J. J. Carr, et al. Coincident linkage of type 2 diabetes, metabolic syndrome, and measures of cardiovascular disease in a genome scan of the diabetes heart study. Diabetes, July 1, 2006; 55(7): 1985 - 1994. [Abstract] [Full Text] [PDF]

				M Nylaende, A Kroese, E Stranden, B Morken, G Sandbaek, A. Lindahl, H Arnesen, and I Seljeflot Markers of vascular inflammation are associated with the extent of atherosclerosis assessed as angiographic score and treadmill walking distances in patients with peripheral arterial occlusive disease Vascular Medicine, February 1, 2006; 11(1): 21 - 28. [Abstract] [PDF]

				E. P. Wijekoon, B. Hall, S. Ratnam, M. E. Brosnan, S. H. Zeisel, and J. T. Brosnan Homocysteine Metabolism in ZDF (Type 2) Diabetic Rats Diabetes, November 1, 2005; 54(11): 3245 - 3251. [Abstract] [Full Text] [PDF]

				M. Kennedy, C. Solomon, T. A. Manolio, M. H. Criqui, A. B. Newman, J. F. Polak, G. L. Burke, P. Enright, and M. Cushman Risk Factors for Declining Ankle-Brachial Index in Men and Women 65 Years or Older: The Cardiovascular Health Study Arch Intern Med, September 12, 2005; 165(16): 1896 - 1902. [Abstract] [Full Text] [PDF]

				G. Levantesi, A. Macchia, R. Marfisi, M. G. Franzosi, A. P. Maggioni, G. L. Nicolosi, C. Schweiger, L. Tavazzi, G. Tognoni, F. Valagussa, et al. Metabolic Syndrome and Risk of Cardiovascular Events After Myocardial Infarction J. Am. Coll. Cardiol., July 19, 2005; 46(2): 277 - 283. [Abstract] [Full Text] [PDF]

				N. P. Kadoglou, S. S. Daskalopoulou, D. Perrea, and C. D. Liapis Matrix Metalloproteinases and Diabetic Vascular Complications Angiology, March 1, 2005; 56(2): 173 - 189. [Abstract] [PDF]

				J. A. Colwell and R. W. Nesto The Platelet in Diabetes: Focus on prevention of ischemic events Diabetes Care, July 1, 2003; 26(7): 2181 - 2188. [Abstract] [Full Text] [PDF]

				D. O. Bates and R. O. P. Jones The Role of Vascular Endothelial Growth Factor in Wound Healing International Journal of Lower Extremity Wounds, June 1, 2003; 2(2): 107 - 120. [Abstract] [PDF]

				J. L. Hall, G. H. Gibbons, and J. C. Chatham IGF-I promotes a shift in metabolic flux in vascular smooth muscle cells Am J Physiol Endocrinol Metab, September 1, 2002; 283(3): E465 - E471. [Abstract] [Full Text] [PDF]

				E. Cosson, F. Paycha, P. Tellier, R. N. Sachs, A. Ramadan, J. Paries, J.-R. Attali, and P. Valensi Lower-Limb Vascularization in Diabetic Patients: Assessment by thallium-201 scanning coupled with exercise myocardial scintigraphy Diabetes Care, May 1, 2001; 24(5): 870 - 874. [Abstract] [Full Text]

				J. L. Hall, J. C. Chatham, H. Eldar-Finkelman, and G. H. Gibbons Upregulation of Glucose Metabolism During Intimal Lesion Formation Is Coupled to the Inhibition of Vascular Smooth Muscle Cell Apoptosis: Role of GSK3{beta} Diabetes, May 1, 2001; 50(5): 1171 - 1179. [Abstract] [Full Text]

				L. Djousse, D. Levy, J. M. Murabito, L. A. Cupples, and R. C. Ellison Alcohol Consumption and Risk of Intermittent Claudication in the Framingham Heart Study Circulation, December 19, 2000; 102(25): 3092 - 3097. [Abstract] [Full Text] [PDF]

				W. T. Meijer, D. E. Grobbee, M. G. M. Hunink, A. Hofman, and A. W. Hoes Determinants of Peripheral Arterial Disease in the Elderly: The Rotterdam Study Arch Intern Med, October 23, 2000; 160(19): 2934 - 2938. [Abstract] [Full Text] [PDF]

				J. L. Hall, C. M. Matter, X. Wang, and G. H. Gibbons Hyperglycemia Inhibits Vascular Smooth Muscle Cell Apoptosis Through a Protein Kinase C-Dependent Pathway Circ. Res., September 29, 2000; 87(7): 574 - 580. [Abstract] [Full Text] [PDF]

				C. M. Akbari, F. B. Pomposelli Jr, G. W. Gibbons, D. R. Campbell, M. C. Pulling, D. Mydlarz, and F. W. LoGerfo Lower Extremity Revascularization in Diabetes: Late Observations Arch Surg, April 1, 2000; 135(4): 452 - 456. [Abstract] [Full Text] [PDF]

				M. McGrae McDermott, S. Mehta, and P. Greenland Exertional Leg Symptoms Other Than Intermittent Claudication Are Common in Peripheral Arterial Disease Arch Intern Med, February 22, 1999; 159(4): 387 - 392. [Abstract] [Full Text] [PDF]

				S. M. Grundy, G. J. Balady, M. H. Criqui, G. Fletcher, P. Greenland, L. F. Hiratzka, N. Houston-Miller, P. Kris-Etherton, H. M. Krumholz, J. LaRosa, et al. Primary Prevention of Coronary Heart Disease: Guidance From Framingham : A Statement for Healthcare Professionals From the AHA Task Force on Risk Reduction Circulation, May 19, 1998; 97(18): 1876 - 1887. [Full Text] [PDF]

				A. S. Brown, Y. Hong, A. de Belder, H. Beacon, J. Beeso, R. Sherwood, M. Edmonds, J. F. Martin, and J. D. Erusalimsky Megakaryocyte Ploidy and Platelet Changes in Human Diabetes and Atherosclerosis Arterioscler. Thromb. Vasc. Biol., April 1, 1997; 17(4): 802 - 807. [Abstract] [Full Text]

				J. D. Curb, K. Masaki, B. L. Rodriguez, R. D. Abbott, C. M. Burchfiel, R. Chen, H. Petrovitch, D. Sharp, and K. Yano Peripheral Artery Disease and Cardiovascular Risk Factors in the Elderly: The Honolulu Heart Program Arterioscler. Thromb. Vasc. Biol., December 1, 1996; 16(12): 1495 - 1500. [Abstract] [Full Text]

				S. F. Aranki, R. J. Rizzo, D. H. Adams, G. S. Couper, N. M. Kinchla, J. J. Collins Jr., and L. H. Cohn Internal Thoracic Artery Flow in Diabetic Patients Vascular and Endovascular Surgery, March 1, 1995; 29(2): 83 - 89. [Abstract] [PDF]

				W. R. Hiatt, S. Hoag, and R. F. Hamman Effect of Diagnostic Criteria on the Prevalence of Peripheral Arterial Disease : The San Luis Valley Diabetes Study Circulation, March 1, 1995; 91(5): 1472 - 1479. [Abstract] [Full Text]